Rating History for 5/26/2022 [Downgrades]
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| ASGN Inc.
(BMO Capital - Jeffrey Silber) |
ASGN | Downgrade | Market Perform (Outperform) |
102.00 (N/A) |
94.00 (100.78) |
7.21% | Details | ||
| Avadel Pharmaceuticals
(Stifel - Paul Matteis) |
AVDL | Downgrade | Hold (Buy) |
2.00 (9.00) |
3.38 (18.09) |
435.21% | Details | ||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 14 more... | |||||||||
